Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
We are engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. We are a Delaware corporation, organized on June 13, 2022. Aspire North America, a California limited liability company was formed on February 22, 2020, and 100% of its ownership was transferred to Aspire Global on September 23, 2020 and was transferred by Aspire Global to Ispire Technology on July 29, 2022. Aspire Science, a Hong Kong corporation, was incorporated on December 9, 2016 and 100% of its equity was transferred to us on July 29, 2022. Ispire International was organized on July 6, 2022. Aspire North America and Aspire Science are our operating companies. Our principal executive offices are located at 19700 Magellan Dr, Los Angeles, CA 90502.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $88.1M | $115.6M | $151.9M | $127.5M |
| Gross profit | $13.3M | $20.8M | $29.8M | $22.6M |
| Operating income | -$988,671.00 | -$4.5M | -$13.9M | -$37.8M |
| Net income | -$1.9M | -$6.0M | -$14.8M | -$39.2M |
| Diluted EPS | -$0.04 | -$0.12 | -$0.27 | -$0.69 |
| Operating cash flow | -$7.6M | -$8.5M | -$18.3M | -$7.4M |
| Free cash flow | -$7.7M | -$9.5M | -$20.3M | -$8.5M |
| Gross margin | 15.1% | 18.0% | 19.6% | 17.8% |
| Operating margin | -1.1% | -3.9% | -9.1% | -29.7% |
| Net margin | -2.1% | -5.2% | -9.7% | -30.8% |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.3M | $39.3M | $41.8M | $26.2M | $20.1M | $30.4M | $20.3M | $18.7M |
| Gross profit | $10.6M | $7.7M | $7.7M | $4.8M | $2.5M | $5.1M | $3.5M | $2.0M |
| Operating income | -$3.4M | -$5.3M | -$7.4M | -$10.6M | -$14.6M | -$2.7M | -$6.9M | -$9.5M |
| Net income | -$3.5M | -$5.6M | -$8.0M | -$10.9M | -$14.8M | -$3.3M | -$6.6M | -$9.5M |
| Diluted EPS | -$0.07 | -$0.10 | -$0.14 | -$0.19 | -$0.26 | -$0.06 | -$0.12 | -$0.17 |
| Operating cash flow | -$1.4M | $3.6M | -$3.2M | -$12.5M | $4.7M | -$1.2M | -$4.0M | $2.0M |
| Free cash flow | -$2.2M | $3.3M | -$3.2M | -$12.7M | $3.7M | -$1.2M | -$4.0M | $1.7M |
| Gross margin | 28.3% | 19.5% | 18.5% | 18.2% | 12.3% | 17.0% | 17.1% | 10.7% |
| Operating margin | -9.2% | -13.4% | -17.6% | -40.4% | -72.7% | -8.9% | -33.9% | -50.8% |
| Net margin | -9.4% | -14.2% | -19.1% | -41.5% | -73.4% | -10.7% | -32.5% | -51.0% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-03-19 | Fargis John | Award | 35,526 | $0.00 | $0.00 | filing |
| 2026-03-19 | Cox Brent | Award | 35,526 | $0.00 | $0.00 | filing |
| 2026-03-19 | Burch Christopher Robert | Award | 35,526 | $0.00 | $0.00 | filing |
| 2026-03-02 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 1,737 | $2.37 | $4,108.01 | filing |
| 2026-03-02 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 1,737 | $2.37 | $4,108.01 | filing |
| 2026-03-02 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 1,163 | $2.41 | $2,798.06 | filing |
| 2026-03-02 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 1,163 | $2.41 | $2,798.06 | filing |
| 2026-03-02 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 100 | $2.38 | $237.80 | filing |
| 2026-02-27 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 984 | $2.38 | $2,341.92 | filing |
| 2026-02-27 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 916 | $2.44 | $2,234.22 | filing |
| 2026-02-27 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 100 | $2.39 | $239.20 | filing |
| 2026-02-26 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 1,900 | $2.41 | $4,569.88 | filing |
| 2026-02-26 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 100 | $2.39 | $238.80 | filing |
| 2026-02-25 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 2,000 | $2.30 | $4,608.80 | filing |
| 2026-02-25 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 1,084 | $2.34 | $2,536.56 | filing |
| 2026-02-25 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 916 | $2.36 | $2,161.67 | filing |
| 2026-02-24 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 1,041 | $2.21 | $2,295.41 | filing |
| 2026-02-24 | Wang Michael Xue· Co-Chief Executive Officer | Buy | 959 | $2.21 | $2,117.57 | filing |
| 2026-02-17 | Pryzbyla Steven P.· CLO and Secretary | Sale | 3,000 | $3.22 | $9,670.20 | filing |
| 2026-02-13 | Pryzbyla Steven P.· CLO and Secretary | Sale | 3,000 | $3.23 | $9,697.20 | filing |
| 2026-02-12 | Pryzbyla Steven P.· CLO and Secretary | Sale | 3,000 | $3.41 | $10,224.90 | filing |
| 2025-11-20 | Fargis John | Sale | 7,500 | $1.95 | $14,625.00 | filing |
| 2025-09-26 | Pryzbyla Steven P.· CLO and Secretary | Sale | 17,046 | $2.64 | $45,001.44 | filing |
| 2025-07-10 | Cox Brent | Award | 29,784 | $0.00 | $0.00 | filing |
| 2025-07-10 | Burch Christopher Robert | Award | 27,178 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.